Skip to content

UroCareBel

Active
Private limited company· 2 yrs active
Rue Chapelle Cléricy 9 ·1341 Ottignies-Louvain-la-Neuve, Belgium
KBO/BCE: BE 0805.749.306
Watch Print / PDF
Age2 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of UroCareBel is 2.9% (moderate). The 2024 annual accounts show equity of €117k and a net result of €114k. The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 1 annual account.

Filing behaviour

From the deposit records, complete market-wide
Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 27-06-2025, 34 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
How we compute the deadline
There is a single filed set of accounts, closing on 31-12. That date is certain, but one observation does not establish the rhythm (a first financial year may run longer than twelve months), so we project no following year. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2024 31-07-2025 27-06-2025 34 d early 2025-00201716

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
Young company
Founded in 2023, under 3 years, statistically higher risk.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
2.9% Moderate
0%0,5%1,5%4%10%≥25%
Young company +No NACE activity registered +Higher-failure-rate region +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€114k
Working capital€110k

Annual accounts & ratios

Source: NBB · 2024
Annual accounts filed on 27-06-2025 with the NBB · fiscal year 2024 · volledig
Fiscal year2024
Depositvolledig
Revenue-
EBITDA€155k
Net profit€114k
Cash flow€115k
Staff costs-
Income taxes€39k
Dividends-
Total assets€153k
Equity€117k
Debt€37k
of which ≤ 1y€37k
of which > 1y-
Working capital€110k
Employees (FTE)-
Ratios (computed)
2024
Current ratio3.99
Quick ratio3.99
Working capital ratio71.5%
Solvency76.1%
Debt / equity0.31
Long-term debt ratio-
Interest coverage101.05
Gross margin-
Net margin-
ROA74.3%
ROE97.7%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2024
Full annual accounts (20 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2024
Balance sheet, Assets
TOTAL ASSETS 20/58€153k
Fixed assets 21/28€7k
Tangible fixed assets 22/27€7k
Current assets 29/58€146k
Amounts receivable within one year 40/41€22k
Cash & bank 54/58€124k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€153k
Equity 10/15€117k
Contributions / capital 10/11€3k
Accumulated profits (losses) 14€114k
Amounts payable 17/49€37k
Amounts payable within one year 42/48€37k
Trade debts payable within one year 44€1k
Income statement
Gross operating margin 9900€155k
Operating result 9901€155k
Financial charges 65€2k
Result before taxes 9903€153k
Income taxes 67/77€39k
Net result for the period 9904€114k
Result to be appropriated 9905€114k
Ratios computed by Checked.

Health barometer

FY 2024 · computed
93 / 100 Excellent
050100
Computed from 4 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.

Directors

Directors & mandates

2 directors
2 of this company's 2 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing below: a director who resigned there may therefore still show here as sitting. See the acts under Publications.
Current directors & mandates
  • SComm NATKA CONSULTINGLegal entity
    Gérant· perm. rep.: Nathalie Calomme
    State Gazette act 24137811 (24-09-2024)
    Current
    24-09-2024 → present
  • Marco RANCAN
    Director
    State Gazette act 24137811 (24-09-2024)
    Current
    12-08-2024 → present
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.This list is read straight from this company's published acts, not from the officer register.

Insolvency mandates

No insolvency mandates (liquidators, administrators) on record for this company.

Legal Structure

NACE primary -
Legal form Private limited company(610)
Incorporation12-09-2023
StatusActive
Postal code1341

Structure & network

Locations & real estate

Registered office

on the map · from the address register
exact location from the address register On OpenStreetMap

Establishment units

1 location
Urocarebel
Rue Chapelle Cléricy 9, 1341 Ottignies-Louvain-la-NeuveActiviteiten van medisch specialisten
since 20232.349.355.836
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area154 m²
Buildings1
Building footprint141 m²
Volume (LiDAR)888 m³
Tallest building9.7 m · ±2 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
25016A0464/00G007 Wallonia 154 m² 1 · 141 m² 9.7 m · 2 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

1 acts
Address history · 1
24-09-2024
Registered-office move
All acts · 1 updated 1 year ago
2024
24-09-2024 Registered office moved to Genappe Registered-office change
  • Rue des Communes 14 à 1470 Genappe

Analysis

Financial profile

4 of 5 axes measured
Health93Profitability100Solvency100Growth-Stability67
90 / 100

Strong profile, led by profitability.

Computed on 4 of 5 axes. Not measured: growth. An unmeasured axis is not a zero: no data was read for it.

Health 93
Profitability 100
Solvency 100
Growth -
Stability 67

Credit advice

verdict per customer and amount

May this customer buy amount X on invoice? Enter the amount and the payment term. This page computes a GREEN, AMBER or RED verdict from them, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Company registry

Company registry (CBE)

Crossroads Bank
Names & trade names
Legal nameFR UroCareBel
Registered office
Rue Chapelle Cléricy 9
1341 Ottignies-Louvain-la-Neuve, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.